MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Free Cash flow
-$3,556K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Stock-based compensation
Accrued expenses and other liabi...
Prepaid expenses and other asset...
Others
Negative Cash Flow Breakdown
Net loss
Inventories
Trade receivables
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-3,072
-2,143
-1,240
-1,955
Depreciation and amortization
196
202
221
164
Provision for inventory obsolescence
85
10
136
33
Provision for product warranties
-
-
214
-
Loss on disposal of property and equipment
-
-
0
-19
Stock-based compensation
1,074
312
500
530
Allowance for credit losses
56
-
137
130
Non-cash lease expense
15
20
18
20
Non-cash interest expense
241
238
242
242
Trade receivables
946
-3,952
3,895
1,836
Prepaid expenses and other assets
-294
148
-228
425
Inventories
1,311
845
-511
865
Accounts payable
-444
-411
-155
328
Accrued expenses and other liabilities
322
-1,759
553
79
Net cash used in operating activities
-3,490
-572
-2,530
-3,536
Purchases of property and equipment
66
-779
-
519
Net cash used in investing activities
-66
779
-
-519
Proceeds from stock option exercises
0
39
-
49
Repayment of finance lease liabilities
5
-9
-
4
Contributions from non-controlling interest
0
-60
-
0
Net cash provided by financing activities
-5
-12
-
45
Effect of exchange rates on cash
41
337
-
-156
Net change in cash and cash equivalents
-3,520
-603
6,605
-4,166
Cash and cash equivalents, beginning of period
31,137
31,740
25,135
31,741
Cash and cash equivalents, end of period
27,617
31,137
31,740
25,135
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Effect of exchange
rates on cash
$41K
(117.45%↑ Y/Y)
Net change in cash
and cash...
-$3,520K
(-44.26%↓ Y/Y)
Canceled cashflow
$41K
Stock-based compensation
$1,074K
(10.61%↑ Y/Y)
Accrued expenses and
other liabilities
$322K
(176.12%↑ Y/Y)
Prepaid expenses and
other assets
-$294K
(32.26%↑ Y/Y)
Non-cash interest
expense
$241K
(-48.94%↓ Y/Y)
Depreciation and
amortization
$196K
(-27.41%↓ Y/Y)
Provision for inventory
obsolescence
$85K
(-50.58%↓ Y/Y)
Allowance for credit
losses
$56K
(-64.10%↓ Y/Y)
Non-cash lease expense
$15K
(-68.75%↓ Y/Y)
Net cash used in
operating activities
-$3,490K
(-80.36%↓ Y/Y)
Net cash used in
investing activities
-$66K
(79.38%↑ Y/Y)
Canceled cashflow
$2,283K
Net cash provided by
financing activities
-$5K
(-110.00%↓ Y/Y)
Net loss
-$3,072K
(61.16%↑ Y/Y)
Inventories
$1,311K
(82.08%↑ Y/Y)
Purchases of property and
equipment
$66K
(-79.38%↓ Y/Y)
Trade receivables
$946K
(121.44%↑ Y/Y)
Accounts payable
-$444K
(-343.96%↓ Y/Y)
Repayment of finance lease
liabilities
$5K
(-50.00%↓ Y/Y)
Buy us a coffee
Apyx Medical Corp (APYX)
Apyx Medical Corp (APYX)